Lyophilization Reveals Hidden Costs of Cold Chain Logistics

This article will challenge your current thinking around cold chain logistics by considering Total Landed Costs (TLC). Life sciences have, understandably, relied upon cold chain support for decades. However, molecular diagnostics has reached a tipping point that challenges the scalability of the cold chain standard. Cold chain’s lack of scalability will inhibit the point-of-care (POC) market from growing to its full potential. Pushing the existing cold chain model down from central laboratories into the many more diversified, lower complexity facilities will require immense growth. In the US alone, there are approximately 230K physician practices, compared to approximately 172K CLIA-certified high-complexity labs. This would result in more than doubling the entire existing cold chain capacity for laboratories.

Lyophilization technology has moved product stability in ambient conditions from a “nice to have” to a “must have” for the total cost, ease of use, and environmental factors. We will focus on the TLC cost comparison of “Going Ambient” vs. cold chain because, for many organizations, the total cost is the primary driver, ahead of environmental impact or ease of use. In performing the analysis, we will reveal the hidden costs of cold chain logistics.

Let's discuss the right solution for your team!